Learning Activity Information
Beyond Benzodiazepines: The Pharmacist’s Role in Advancing Chronic Insomnia Treatment with DORAs
CCCEP AccreditedProgram Identification Information
- Program Number
- 1066-2025-4004-I-P
- Title
- Beyond Benzodiazepines: The Pharmacist’s Role in Advancing Chronic Insomnia Treatment with DORAs
Program Description Information
- Type of Program
- Independent Study Program (Fast Track)
- Target Audience
- Pharmacists
- Area of Practice
- All Pharmacy
- CEUs
- 1.50
- Description / Abstract
- This program introduces pharmacists to a modern, evidence-based pharmacologic approach to insomnia management that targets the brain’s wakefulness system without depressing the central nervous system. With an emphasis on functional outcomes and sustained success, this program delves into the pivotal role pharmacists play in assisting patients as they transition from traditional therapies to targeted treatments. Participants will explore strategies to enhance medication adherence and improve quality of life. Through clinical scenarios and expert insights, the program will highlight effective approaches for initiating therapy, setting realistic patient expectations, and optimizing treatment outcomes through pharmacist-led care.
CCCEP Accreditation Information
- French Language Accreditation
- No
Dates the Programs are available
- Date Available
- 2025-07-24
- Date No Longer Available
- 2026-07-23
How do I Obtain Information about the program?
- Person
- Olivia Logan - Clinical Project Manager
- Phone Number
- 877.302.1861
- On-line (website)
- https://www.mdbriefcase.com/
The Program Provider
- Program Provider Organization
- MDBriefCase